Company Snapshot
Hercules Capital provides capital to growing technology and biotechnology companies and distributes a substantial part of its earnings to shareholders. This independent ChatGPT analysis assesses sustainable income, capital preservation and the price paid for both, using per-share earnings, credit quality and financing.
Updated October 30, 2026. Author: ChatGPT. Financial data cover Q3 2026 through September 30. Results and the conference call were released on October 29. Valuation uses the October 29 closing price of USD 16.90, before results were released after the NYSE close. Both scores follow methodology 1.2.
| Item | Current assessment |
|---|---|
| Company and ticker | Hercules Capital Inc., common stock, NYSE HTGC |
| Sector and type | Venture debt and growth-company financing; internally managed BDC |
| Investment character | USD dividend income with specialized credit risk |
| Thesis status | Active; the base dividend remains covered despite much lower prepayments |
| Thesis confidence | Medium; a smaller total-payout cushion and more expensive financing |
| Business strength | 7.2/10, assessed October 30, 2026, methodology 1.2 |
| Price attractiveness | 5.8/10 at USD 16.90, October 29, 2026 close; assessed October 30, three-year horizon, methodology 1.2 |
| Horizon | Multi-year, reviewed after each set of results |
| Base dividend | USD 0.40 per share quarterly |
| Supplemental distribution | USD 0.07 announced for Q3; USD 0.47 total |
| Q3 NII per share | USD 0.47; approximately 118% base-dividend coverage and 100% total-payout coverage |
| NAV per share | USD 12.26 as of September 30, 2026 |
| Reference price | USD 16.90, October 29, 2026 close, before the results release |
| Price to NAV | 1.378×, approximately 37.8% premium |
| Gross indicated yield | 9.47% on the base rate; 11.12% if the supplement continues |
| Indicative market capitalization | USD 3.20 billion using the reference price and 189.55 million shares reported as of October 22 |
Sources: Q3 2026 results, 10-Q, October 29 call, October 27 dividend announcement and historical prices. Multiples, yields and market capitalization are ChatGPT calculations. Annualizing the rates does not constitute a newly declared dividend for the next twelve months.
The thesis in 30 seconds: Lower prepayments reduced NII, but the base dividend remains covered. NAV is growing and overall credit quality is manageable. However, the total payout has virtually no cushion, and more expensive financing limits the benefit of portfolio growth. HTGC remains a higher-quality specialized income platform whose NAV premium still requires good execution.
What matters most: recurring NII per share, separate coverage of base and total distributions, PIK collection, credit-rating migration, NAV per share and financing costs. HTGC’s dividend can remain stable while its share price falls substantially.
Dividend Investment Thesis
HTGC can generate attractive long-term income through specialized lending to companies that have already raised substantial equity but need more capital for growth. It receives interest and fees, sometimes with participation in future success through warrants.
Three conditions support the thesis:
- Borrower-selection discipline. Loans must match the company’s financial position, cash burn and ability to raise further capital. Technology and life-sciences expertise is valuable when it limits losses.
- Shareholder economics. Internal management and Hercules Adviser contributions can improve the income-to-cost balance. Platform growth must translate into per-share results.
- A sustainable income base. Ordinary earnings must cover the base dividend with a cushion even with weaker prepayments and normalized expenses. Q3 passed that test for the base rate, but does not yet demonstrate a lasting cushion for the full payout.
What must hold: manageable credit quality, portfolio renewal on reasonable terms and capital issuance supporting NAV and sustainable earnings per share. Platform size alone is insufficient. Current results; previous Q2 call.
HTGC alongside ARCC
ARCC offers a broader private-company lending platform. HTGC adds technology and life-sciences specialization and internal management. Both share credit-cycle and dollar-income risk; combining two BDCs does not diversify like combining different business types.
Analytical view: HTGC can complement broader BDC exposure, but requires separate scrutiny of venture funding and its NAV premium.
Business & Income Sources
Hercules mainly provides secured loans to venture-backed companies and selected private-equity-backed businesses. Debt supplements equity capital. Some borrowers still require external financing and may not be sustainably profitable.
At September 30, the debt portfolio covered 137 companies, with a fair value of approximately USD 4.65 billion. Technology and life sciences remain roughly balanced; the call indicates that approximately 89% of loans are first-lien. This mitigates some risks but does not guarantee recovery on default. 10-Q; Q3 call.
Earnings come from interest, fees and other contractual income. Prepayments can accelerate recognition of some income. Equity investments and warrants can generate gains but also change NAV through private-company valuations.
Scope distinction: approximately USD 6.5 billion of AUM includes both the public BDC and Hercules Adviser funds. HTGC shareholders do not directly own all those assets on the BDC balance sheet. Results announcement.
AI and software risk — management’s statement: The new call describes exposure through energy, networking and other supporting industries rather than direct GPU financing. Analytically, that limits one specific risk but does not eliminate the possibility that AI weakens some software borrowers. Q3 call.
Competitive Advantages
Specialization and relationships. Hercules understands technology and biotechnology companies and has relationships with their equity investors. This can help source transactions, assess borrower liquidity and resolve problems.
Internal management. HTGC employs its own team. Its economics include salaries and operating costs instead of an equivalent external management- and incentive-fee structure. Scale can spread costs, but internal management must still control compensation and loan quality.
Hercules Adviser. The wholly owned subsidiary manages external funds. It contributed approximately USD 6.8 million to BDC NII in Q3: a USD 2.1 million dividend and USD 4.7 million of shared-cost reimbursements, versus USD 7.0 million total in Q2. Higher AUM should therefore not automatically be translated into an immediately higher quarterly contribution to HTGC. 10-Q; CFO commentary.
These advantages strengthen the income thesis if credit standards and transparent allocation of transactions between the BDC and funds are maintained.
Dividend Sustainability
Base and supplemental distributions
On October 27, the company announced a USD 0.47 Q3 distribution, comprising a USD 0.40 base dividend and USD 0.07 supplement. The record date is November 10, 2026, with payment on November 17, 2026. Current announcement. The previous Q2 distribution had the same rate.
The supplement follows USD 0.28 divided into four quarterly USD 0.07 installments, announced in February for 2026. This schedule cannot automatically be extended into future years. Annual filing and subsequent events.
| Income at an unchanged rate | Per share | Per 100 shares |
|---|---|---|
| Base quarterly dividend | USD 0.40 | USD 40 |
| Latest total quarterly distribution | USD 0.47 | USD 47 |
| Annualized base dividend | USD 1.60 | USD 160 |
| Annualized including supplement | USD 1.88 | USD 188 |
All amounts are gross, before taxes and fees. A long-term income plan should rely on the regular rate; supplemental income depends on further company decisions.
Distribution coverage
| Metric | Q2 2026 | Q3 2026 |
|---|---|---|
| NII per share | USD 0.50 | USD 0.47 |
| Base-dividend coverage | 125% | 117.5%; the company reports approximately 118% |
| Total-distribution coverage | Approximately 106% | Approximately 100% |
| Cushion above base dividend | USD 0.10 per share | USD 0.07 per share |
| Cushion above total payout | USD 0.03 per share | Approximately zero |
NII is net investment income after operating and financing expenses, before investment gains and losses. It includes PIK, so coverage is not entirely cash-based. Ratios are ChatGPT calculations using reported rounded amounts. Q3 results.
Estimated spillover taxable income fell to USD 167.8 million, approximately USD 0.88 per period-end share, versus USD 171.7 million in Q2. Spillover supports distribution flexibility but is not a separate cash reserve and does not replace sufficient ordinary earnings. Results announcement.
Independent ChatGPT assessment: Q3 supported base-dividend sustainability under weaker prepayments. The full distribution, however, consumes virtually all reported NII. The supplement therefore remains more sensitive to earnings than the base rate.
Loan Portfolio & Earnings Quality
Earnings with lower prepayments
Q3 investment income was USD 140.1 million and NII USD 87.3 million. The CFO reported non-GAAP core investment income of USD 135.7 million, versus USD 134.4 million in Q2. Core investment income is not core NII after expenses: its growth alone does not establish growth in sustainable earnings per share. Results; call.
Prepayments fell from USD 572.1 million to USD 148.3 million, below July guidance of USD 200–300 million. This explains much of the difference from a strong Q2 and should not automatically be treated as permanent deterioration in the core business. A return of fees is not guaranteed either. Q3 results.
Troubled loans and ratings
The number of nonaccrual loans remained two, with cost and fair values of approximately USD 18.8 million and USD 13.2 million, or 0.4% and 0.3% of the total investment portfolio. Both percentages increased from Q2. The same number does not mean the same borrowers or unchanged problem severity. Results.
The overall rating distribution improved: grades 1 and 2 increased to 68.6%, and grade 3 fell to 30.0%. Grades 4 and 5 combined fell from 1.9% to 1.4%, but grade 5 alone increased from 0.1% to 0.3%. The average internal rating improved from 2.17 to 2.12. The aggregate shift is favorable, but individual weak spots remain. Results, portfolio-quality table.
July commentary about resolving one troubled position was historical Q2 information. Current conclusions depend on the new aggregate data and actual collections, rather than extending one earlier success to the entire portfolio. Previous Q2 call.
PIK and actual collection
PIK is interest added to the receivable instead of paid immediately. Its share of income fell from 8.3% to approximately 7.5%; management says the company collected USD 18.5 million of previously accrued PIK in Q3. A declining share combined with collection is more favorable than accounting income alone. 10-Q; Q3 call.
Contractual PIK still depends on the borrower’s future ability to pay. Assessment must distinguish PIK arising under original terms from PIK related to financial distress; subsequent cash collection is the decisive check.
Key KPIs
| Metric | Q2 2026 | Q3 2026 | What to monitor |
|---|---|---|---|
| NII per share | USD 0.50 | USD 0.47 | Cushion after expense normalization |
| Base / total payout | USD 0.40 / 0.47 | USD 0.40 / 0.47 | Separate coverage of each |
| NAV per share | USD 12.15 | USD 12.26 | Value growth after distributions |
| Nonaccruals, cost / fair value | 0.3 / 0.1% | 0.4 / 0.3% | Problem severity and collection |
| Grades 4 + 5 | 1.9% | 1.4% | Migration within weaker categories |
| Average internal rating | 2.17 | 2.12 | Lower means a better rating |
| PIK share of income | 8.3% | Approximately 7.5% | Collection and restructurings |
| Core yield | 12.0% | 11.9% | New-loan margins |
| Average debt cost | 5.2% | 5.4% | Refinancing impact |
| Net GAAP leverage | 1.018× | 1.090× | Capacity to absorb credit losses |
| BDC liquidity | USD 652.9 million | USD 506.6 million | Conditions on available funding |
| Adviser contribution to NII | USD 7.0 million | USD 6.8 million | Per-share benefit |
Periods end June 30 and September 30, 2026. Sources: supplied Q2 call, Q3 results, 10-Q and Q3 call. Historical metrics are not estimates of the portfolio’s current daily value.
Management, Balance Sheet & Capital
Scott Bluestein leads the company as CEO and chief investment officer. Seth Meyer became president and Andrew Olson became CFO. The dividend thesis depends on continued credit discipline and sensible financing.
Leverage increased again in Q3: gross GAAP 1.111×, net GAAP 1.090×; regulatory leverage excluding SBA financing 0.961×, net regulatory leverage 0.940×. These definitions differ and must not be conflated. Higher leverage finances growth but reduces the loss cushion. Q3 results.
BDC liquidity at September 30 was USD 506.6 million: USD 48.3 million cash, USD 383.3 million available credit facilities and USD 75.0 million SBA capacity, subject to applicable conditions. The debt portfolio grew by USD 252.9 million at cost in Q3. The October issuance occurred after this balance sheet; its entire proceeds cannot simply be added to September unrestricted cash without allowing for refinancing. 10-Q; results.
More recent events
- September 9, 2026: Hercules Adviser announced more than USD 2.3 billion in investable capital across its structures. This is fund capital, not additional equity directly attributable to HTGC shareholders. Hercules Adviser announcement.
- October 5–8, 2026: Following October 5 pricing, HTGC completed USD 400 million of unsecured notes on October 8, with a 6.70% coupon and October 8, 2029 maturity. Completion is confirmed by the company announcement and October 8 8-K. Intended use for refinancing, investments and general corporate purposes is the company’s statement, not evidence that all proceeds have already been deployed.
- October 13, 2026: Forms 4 for Seth Meyer, Scott Bluestein, Kiersten Botelho and Christian Follmann report shares withheld for taxes on restricted-stock vesting on October 9, code F. These are not announcements of voluntary open-market sales and do not independently change the business assessment.
- October 16, 2026: Fitch affirmed the company and unsecured-debt rating at BBB−, with a stable outlook. This is a rating-agency opinion, not a dividend-safety guarantee. Company announcement.
Capital access supports the business, but refinancing older obligations can raise funding costs. The resulting spread between loan yields and total costs matters more than capital raised alone.
After not using the ATM in Q2, the company sold approximately 2.3 million shares for USD 39.2 million net proceeds in Q3. Above-NAV issuance can benefit NAV per share, but the increased share count also raises the requirement for earnings growth. 10-Q.
Risks / Bear Case
Borrowers depend on new capital. A funding stop or lower valuations can quickly shorten companies’ cash runways. Previously invested venture capital is not a promise of another round.
Technology and life sciences. A technology borrower can lose competitiveness; a biotechnology borrower can fail in development or commercialization. Senior collateral does not determine actual default recovery.
Rates and portfolio renewal. Approximately 98% of loans have floating rates with floors. Management says almost 60% of prime-linked loans were at their floor in Q3, versus 75% in Q2. Revenue sensitivity to interest rates is therefore not constant; the net effect also depends on liabilities and newly originated loans. Q3 call.
Competition and underwriting. Aggressive competing offers can reduce yields or weaken loan terms. The key is maintaining discipline as the platform grows. Collateral and good historical results do not eliminate the risk of future bad loans. 10-Q, business risks.
PIK and private-asset valuation. Accounting income may precede cash, and NAV may not precisely reflect eventual recovery on troubled positions.
NAV premium. A lower willingness to pay for quality can reduce the share price even with a stable dividend. This differs from the company’s ability to distribute income.
Currency impact. Dollar distributions have a variable koruna value.
The main adverse scenario involves borrowers struggling to raise capital, more credit problems and weaker NII. The company reduces the supplement and possibly the base dividend. NAV and the share-price premium decline simultaneously, so income may not offset the capital loss.
Valuation & Total Return
ChatGPT produces the calculations and valuation scenarios. Share-price inputs are dated to the analysis; they are not continuously updated market data.
Different outcomes. Different values.
16.90 USD · October 29, 2026 · 16:00 EDT · close before results
HTGC should be assessed through a combination of price to NAV, sustainable NII and separate dividend yields. NAV is an accounting estimate of assets less liabilities; the market price also includes expected future earnings and platform value.
At the October 29 close of USD 16.90, against September NAV of USD 12.26, the premium is approximately 37.8%. The price already assumes quality execution; high income alone does not prove undervaluation. Quote, NAV; interpretation is ChatGPT’s analytical judgment.
Price sensitivity
The following ChatGPT sensitivity calculation holds NAV at USD 12.26, the annual base rate at USD 1.60 and the annual total rate at USD 1.88. These are neither price targets nor forecasts of future dividends.
| Price to NAV | Implied price, USD | Base-dividend yield | Yield including supplement |
|---|---|---|---|
| 1.00× | 12.26 | 13.05% | 15.33% |
| 1.10× | 13.49 | 11.86% | 13.94% |
| 1.20× | 14.71 | 10.88% | 12.78% |
| 1.30× | 15.94 | 10.04% | 11.80% |
| 1.40× | 17.16 | 9.32% | 10.95% |
| 1.50× | 18.39 | 8.70% | 10.22% |
Yields use unrounded prices and assume the respective payout is maintained. Changes in NAV or dividends require new inputs.
Premium-loss risk
With NAV unchanged, a valuation decline from 1.378× to 1.10× would imply approximately USD 13.49, a decline of about 20.2%. One full annual distribution of USD 1.88 would produce a gross total result of approximately minus 9.1%, without reinvestment. The calculation uses an unrounded price of USD 13.486.
This illustrates sensitivity rather than an expected outcome. Dividend income and capital performance must be assessed together.
What Would Change the Assessment?
The following monitoring signals are analytical thresholds for reassessment, not automatic trading instructions.
| Signal | Assessment implication |
|---|---|
| NII below the base dividend for two consecutive quarters | Investigate a lasting mismatch between earnings and regular income |
| NII covers the base but repeatedly fails to cover the full payout | Reassess supplemental expectations separately |
| Nonaccruals above 1% at cost or rising rapidly | Examine new borrowers, recovery and NII impact |
| Grades 4 and 5 above 5% of the debt portfolio | Material weakening of the credit profile |
| NAV falls more than 5% from the fixed Q2 2026 baseline of USD 12.15 | Separate revaluation, losses and issuance effects |
| PIK rises because of borrower distress while collection weakens | Lower reported-income quality |
| Rising leverage alongside a weaker portfolio | Less capacity to absorb further losses |
| Supplemental reduction | Changed income expectations; assess the core thesis according to the cause |
| Base-dividend reduction | Material damage to the income thesis |
| A higher premium without sustainable NII and NAV growth | Weaker price–risk balance |
No threshold decides alone. The most serious combination is declining earnings and NAV, rising troubled loans and weaker financing access.
Repeated preservation of a base-dividend cushion under ordinary prepayments and expenses, stable NAV, manageable refinancing and per-share earnings growth without weaker underwriting would strengthen the assessment.
Current View
HTGC’s income thesis remains active. Q3 showed a base-payout cushion even with substantially lower prepayments. The full distribution has a minimal cushion, however, and operating growth is accompanied by more expensive financing.
The overall picture does not justify a major increase or decrease in the business assessment: better internal-rating distribution and a lower PIK share are balanced against higher leverage, debt costs and nonaccrual percentages. Low problem-loan frequency must not obscure severity.
At the reference price, the base rate offers approximately 9.47% gross indicated yield, or 11.12% including the supplement. The NAV premium means income can accompany a substantial price decline. The independent valuation below therefore does not mechanically extend the latest full distribution.
Management’s Q4 outlook, not reported results: core yield of 11.8–12.0%, prepayments of USD 200–300 million and higher investment income and NII than in Q3. Costs are also expected to rise; SG&A guidance is USD 27.5–28.5 million, above Q3. A fee recovery cannot therefore be passed through fully to net earnings. Q3 call.
Confidence in both assessments remains medium. Available results permit analysis, but private credit assets, repayment timing and financing costs leave material uncertainty.
Business strength
Business strength: 7.2/10. Assessed October 30, 2026. Methodology: 1.2. ChatGPT’s independent assessment is the arithmetic mean of five equally weighted areas under the Assessment methodology. New evidence changes the supporting analysis, not the overall judgment. The share price is excluded.
| Area | Score | Main evidence and limitation |
|---|---|---|
| Competitive advantage | 7.0/10 | Specialization, relationships and internal management remain advantages. Competition limits pricing power. |
| Demand durability | 7.0/10 | Platform and loan-portfolio growth support financing demand, but income is not independent of the venture cycle. |
| Management execution | 8.0/10 | Q3 NAV per share grew and aggregate internal credit ratings improved. This needs confirmation in a worse cycle. |
| Business economics | 7.0/10 | Earnings under weaker prepayments still cover the base dividend. The total payout has a minimal cushion and refinancing is more expensive. |
| Financial resilience | 7.0/10 | Available financing and an affirmed investment-grade rating support resilience. Higher leverage and lower September liquidity reduce room for error. |
Calculation: (7.0 + 7.0 + 8.0 + 7.0 + 7.0) / 5 = 7.2. Version 1.2 requires a 1–10 scale and one decimal place; retained scores are not a mechanical recast of an old scale.
Brief rationale: HTGC has documented specialization and internal-management cost advantages. New results support base-income resilience but do not establish exceptional immunity to headwinds. Improving credit metrics are balanced by higher financing costs and leverage; 7.2/10 is unchanged.
Main weakness: Credit losses can hit NAV and earnings simultaneously. Aggregate rating improvement does not exclude deterioration in individual borrowers; rising nonaccrual percentages call for specific collection checks rather than an automatic conclusion of widespread problems.
Assessment confidence: medium. Quarterly data are supported by primary documents; private-asset valuation and resilience in a weaker venture cycle remain uncertain.
Condition for change: Four quarters of rising NAV per share, NII of at least USD 0.44 under ordinary prepayments and non-deteriorating ratings would support an increase. Nonaccruals above 2% at cost or two quarters of NII below the base dividend would particularly support a reduction.
Price Attractiveness
Price attractiveness: 5.8/10 at USD 16.90. Quote date: October 29, 2026, NYSE close at 16:00 EDT. Assessed October 30, 2026. Horizon: three years through October 2029. Methodology: 1.2. HTGC common stock. Quote source. The closing price precedes results released after the market closed; it is not presented as a price fully reflecting those results.
The entry price is approximately 1.378× NAV, or a 37.8% premium. This uses September 30 accounting NAV rather than a daily estimate. The premium requires a cushion against weaker earnings or a lower willingness to pay for quality.
The assumptions below are independent ChatGPT analysis, not management guidance. Previous terminal scenario values are retained: the new quarter does not invalidate them, and higher current NAV alone does not justify raising targets. Current NAV implies approximately 2% annual growth to the base-case USD 13.00; the adverse case assumes a roughly 21% decline. Debt and issuance effects are included in per-share values.
| Item | Base scenario | Adverse scenario |
|---|---|---|
| Business assumptions | Gradual lending growth; core yield around 11.8–12.0%, without a major credit shock. Long-run quarterly NII approximately USD 0.44–0.47; terminal NAV USD 13.00 per share. | Weaker venture funding, credit losses and margin pressure. Quarterly NII approximately USD 0.32; terminal NAV USD 9.72. |
| Financing and share count | Average debt cost gradually reaches 5.5–6.0%, leverage about 1×. Shares increase about 10% over three years through above-NAV issuance; volume growth is not automatically per-share growth. | Some refinancing at 7–7.5%; leverage rises after losses. Share count roughly flat; no assistance assumed from high-premium issuance. |
| Future valuation | 1.25× NAV. | 0.90× NAV. |
| Price in three years | USD 16.25 = 13.00 × 1.25. | USD 8.75 ≈ 9.72 × 0.90. |
| Three-year dividends | USD 4.80 = 3 × 1.60. Base only, without a permanent supplement. | USD 4.16 = 1.60 + 1.28 + 1.28. Base cut 20% from year two, without supplement. |
| Three-year total return | +24.6%. | −23.6%. |
Return calculation: (price in three years + dividends) / 16.90 − 1. All in USD, before taxes, fees and currency effects, without reinvestment. The adverse calculation uses the unrounded USD 8.748 price. NAV already deducts liabilities; debt is not deducted again. The adverse case is neither the worst possible outcome nor an estimate of maximum interim drawdown.
Brief rationale: The business thesis holds, but entry price rose faster than NAV since October 15. Under unchanged scenarios, base return falls from +28.8% to +24.6%, and adverse return worsens from −21.0% to −23.6%. High base income remains appealing, but the safety margin is limited. The modest reduction to 5.8/10 reflects weaker price–risk compensation, not deterioration in the business thesis.
Main weakness: The base case assumes the dividend continues and a NAV premium persists. Credit losses or more expensive capital can weaken both assumptions simultaneously.
Assessment confidence: medium. Price and September NAV are verified, but future credit losses and the multiple remain estimates. The closing price also precedes results: this is an assessment at a stated price, not a claim about an available trading price.
Condition for change: The original indicative thresholds remain: around USD 14.60 or below, with the business unchanged, base return would exceed 44%; above USD 18.20, disappointment risk would rise. Lower sustainable NII or NAV would weaken the assessment even at a cheaper share price. These are analytical reassessment thresholds, not automatic trading instructions.
Main sources for both scores
- Q3 2026 results and 10-Q, released October 29, 2026, covering the period through September 30; primary financial and credit data. Q2 results remain a comparison source.
- Public Q3 2026 transcript, October 29 call, Quartr through Stock Analysis; management commentary and guidance. The supplied Q2 transcript was read for comparison.
- Q3 dividend announcement, October 27, 2026; rates and November dates. The older Q2 announcement is historical context.
- Completed note issuance, October 8, 2026; USD 400 million, 6.70% coupon, October 8, 2029 maturity.
- HTGC historical quotes, USD 16.90 closing price on October 29, 2026, verified October 30; historical data from S&P Global Market Intelligence.
- Hercules Adviser development, published September 9, 2026; fund investable capital above USD 2.3 billion.
- Fitch rating affirmation, October 16, 2026; BBB−, stable outlook. This is an external judgment, not ChatGPT’s score.
Thesis History / Updates
| Date | Event | Thesis impact |
|---|---|---|
| February 4, 2026 | USD 0.28 supplement announced in four installments | The 2026 supplement has its own schedule |
| July 28, 2026 | Q2 distribution announced | USD 0.40 base and USD 0.07 supplement |
| July 30, 2026 | Q2 results and call | USD 0.50 NII, USD 12.15 NAV; 125% base coverage |
| August 18, 2026 | Q2 payment date | USD 0.47 total gross income per share |
| September 9, 2026 | Adviser exceeded USD 2.3 billion investable capital | More capacity for fund-management development |
| October 5, 2026 | USD 400 million notes priced | Funding access; 6.70% coupon |
| October 7, 2026 | Dividend analysis created | Active thesis, subject to recurring-earnings and valuation checks |
| October 8, 2026 | USD 400 million unsecured-note issuance completed, 6.70% coupon | Confirmed funding access; October 8, 2029 maturity |
| October 11, 2026 | First methodology 1.0 assessment | Business strength 7.2/10; price attractiveness 6/10 at USD 16.51, October 9 close; three-year horizon |
| October 13, 2026 | Four Forms 4 for October 9 transactions | Tax withholding on vested shares; no reason to change the business score |
| October 15, 2026 | Review following October 11 assessment; methodology 1.1 | Business strength 7.2/10 and component judgments unchanged; attractiveness 6.0/10 at the October 14 close of USD 16.34. Base/adverse three-year returns +28.8%/−21.0%. Previously documented completed issuance corrected in section 8. |
| October 27, 2026 | Q3 distribution announced | Base and supplement unchanged; USD 0.47 total |
| October 29, 2026 | Q3 results and call | USD 0.47 NII, USD 12.26 NAV; base coverage sustained under weaker prepayments, with higher costs and leverage |
| October 30, 2026 | Methodology 1.2 update | Business strength unchanged at 7.2/10; attractiveness 5.8/10 at USD 16.90, October 29 close. Scenarios +24.6%/−23.6%. |
| Next Q4 and full-year 2026 results | Future review | NII after expense normalization, credit quality, refinancing and dividend capacity |
History retains documented company events and independent financial assessments. Price movements change attractiveness but need not change the business thesis.
Historical October 11 and 15 assessments remain with their original methodology versions and prices. Version 1.2 adjusted the lower scale boundary while preserving five areas, weights and the three-year horizon. Historical scores have not been recalculated, and a version change does not represent a business change.
Sources
- Public Q3 2026 transcript, October 29, 2026 call; official results release and 10-Q for the period ended September 30, 2026. Principal current sources.
- HTGC Q2 2026 transcript, supplied July 30, 2026 call; historical comparison.
- Q2 2026 results release, released July 30; capital, spillover, liquidity and platform-versus-BDC distinction. Historical comparison; Q3 is the current period.
- Current Q3 dividend announcement, October 27, 2026; historical Q2 announcement, July 28, 2026.
- Supplemental schedule, subsequent events in the 2025 annual filing.
- HTGC historical prices, latest closing price October 29, 2026; checked October 30.
- Hercules Adviser development, September 9, 2026.
- October note pricing, October 5, 2026.
- Financial results and company releases, checked October 30, 2026. The IR calendar remains an indicative reference.
ChatGPT authors the conclusions, scenarios, scores and monitoring thresholds. Management guidance is separately identified. Returns are gross scenario estimates without guaranteed income; Q3 2026 is the latest reported period.
Was this analysis useful to you?